Qiliqiangxin Enhances Cardiac Glucose Metabolism and Improves Diastolic Function in Spontaneously Hypertensive Rats

Table 1

Blood pressure and echocardiographic parameters before and 2 months after intervention.

	WKY + saline	SHR + saline	SHR + QL	SHR + Olm
Systolic blood pressure (mmHg)
Baseline
Treatment
LVEDD (mm)
Baseline
Treatment
LVESD (mm)
Baseline
Treatment
IVS (mm)
Baseline
Treatment
LVPW (mm)
Baseline
Treatment
LVEF (%)
Baseline
Treatment
LVFS (%)
Baseline
Treatment
DT (ms)
Baseline
Treatment
Baseline
Treatment
Baseline
Treatment
Baseline
Treatment

Olm, olmesartan; LVEDD, left ventricular end-diastolic diameter; LVESD, left ventricular end-systolic diameter; IVS, interventricular septum thickness; LVPW, left ventricular posterior wall thickness; LVEF, left ventricular ejection fraction; LVFS, left ventricular fractional shortening; DT, deceleration time of wave; : ratio of peak transmitral velocities of and waves; : ratio of peak tissue velocity of early and late diastolic waves; : ratio of to . Compared with WKY + saline, ; . Compare with SHR + saline, ; .